semaglutide and alcoholism New Research: Oral Reduced Heavy Drinking in Adults with Alcohol Use Disorder Once-weekly semaglutide versus placebo in

*In a 68- and 72-week clinical trial studying Wegovy (2.4 mg) in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)

Research confirms its effectiveness in increasing melanin production, offering a safer alternative to prolonged UV exposure (1)

Dihexa contains several amide bonds connecting its amino acid-derived segments

Patients seeking weight loss treatment should not attempt to calculate or self-administer doses of any unlicensed injectable compound

S -conjugates, and glutathione complexes)